Hong Kong develops integrated test for children with difficult-to-treat leukaemia
China | News | 0 Comment | 29 Sep, 2022
Children with relapsed acute myeloid leukaemia (AML) who develop drug resistance generally lack treatment options and ar...Read more
WuXi STA opens first high potency oral drug product manufacturing facility
China | News | 0 Comment | 28 Sep, 2022
WuXi STA, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the ope...Read more
Inventiva and Sino Biopharm ink NASH deal for more than $300 M
China | News | 0 Comment | 27 Sep, 2022
French firm Inventiva and Chia Tai-Tianqing Pharmaceutical Group Co. (CTTQ), a subsidiary of China-based Sino Biopharm, ...Read more
Hong Kong fosters research and innovation on AI-driven computational imaging
China | News | 0 Comment | 26 Sep, 2022
The Hong Kong Polytechnic University (PolyU) has signed a cooperation agreement with Guangdong OPPO Mobile Telecommunica...Read more
China's BGI donates Huo-Yan Air Laboratory to Thailand
China | News | 0 Comment | 20 Sep, 2022
On September 19, 2022, Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health, Dr Satit Pitutecha, Dep...Read more
Menarini and SciClone ink €115 M deal to address rising prevalence of AMR in China
China | News | 0 Comment | 21 Sep, 2022
A. Menarini Asia-Pacific Holdings, part of The Menarini Group, and SciClone Pharmaceuticals (Holdings) have entered into...Read more
MGI unveils ultra high speed gene sequencer in China
China | News | 0 Comment | 20 Sep, 2022
China-based MGI Tech has launched DNBSEQ-G99, the latest model of the gene sequencer with mid to low range throughp...Read more
Advanced MedTech acquires China’s market-leader in urology
China | News | 1 Comment | 19 Sep, 2022
Integrated urology leader Advanced MedTech Holdings (AMTH) has announced the acquisition of a majority interest in ...Read more
Everest Medicines appoints new CEO to lead next stage of company growth
China | News | 0 Comment | 19 Sep, 2022
China-based Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative phar...Read more
China promotes development of new cell therapeutic drugs
China | News | 0 Comment | 16 Sep, 2022
China-based Biocytogen Pharmaceuticals has collaborated with FineImmune Biotechnology to co-develop cell-based therapeut...Read more
Hong Kong-based startup Great Bay Bio secures $15M funding
China | News | 0 Comment | 15 Sep, 2022
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...Read more
China approves inhaled vaccine as COVID-19 booster dose
China | News | 0 Comment | 12 Sep, 2022
CanSino Biologics Inc has announced that the National Medical Products Administration of China (NMPA) has granted the co...Read more
Neovii & Fosun Pharma ink agreement for bringing transplantation medicine to China
China | News | 0 Comment | 13 Sep, 2022
Neovii Pharmaceuticals, a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical...Read more
Hong Kong introduces Long COVID Chinese Medicine Rehabilitation Programme
China | News | 0 Comment | 08 Sep, 2022
The School of Chinese Medicine at Hong Kong Baptist University (HKBU) has launched the Everbright Care • Long COVID...Read more
Zenas BioPharma appoints new Chief Medical Officer
China | News | 0 Comment | 08 Sep, 2022
Zenas BioPharma, a global biopharmaceutical company having operations in the US & China, has announced the appointme...Read more
China's Sinovac makes progress with trivalent COVID-19 vaccine
China | News | 0 Comment | 07 Sep, 2022
China-based Sinovac Biotech has announced that the Chilean Public Health Institute (Instituto de Salud Pública, I...Read more
China approves AstraZeneca's Forxiga for CKD in patients with & without type-2 diabetes
China | News | 0 Comment | 06 Sep, 2022
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Ch...Read more
HitGen and Unison Medicines join hands to develop anti-infectives
China | News | 0 Comment | 05 Sep, 2022
Vernalis Research, a fully owned subsidiary of Chinese firm HitGen Inc., and US-based Unison Medicines Inc. have announc...Read more